| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |